Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID149 | SQRFPKAEF | Albumin | Plasma | NA | MALDI-TOF | Normal | NA | 17269714 |
| CancerPDF_ID150 | GEYKFQNAL | Albumin | Plasma | NA | MALDI-TOF | Normal | NA | 17269714 |
| CancerPDF_ID151 | GEYKFQNALL | Albumin | Plasma | NA | MALDI-TOF | Normal | NA | 17269714 |
| CancerPDF_ID152 | TYVPKEFNAET | Albumin | Plasma | NA | MALDI-TOF | Normal | NA | 17269714 |
| CancerPDF_ID153 | VRYTKKVPQVSTPTL | Albumin | Plasma | NA | MALDI-TOF | Normal | NA | 17269714 |
| CancerPDF_ID154 | LVRYTKKVPQVSTPTL | Albumin | Plasma | NA | MALDI-TOF | Normal | NA | 17269714 |
| CancerPDF_ID199 | HKSEVAHRFKDLGEENFKALVL | Serum albumin | Serum | 2567.3659 | MALDI-TOF | "Non-small cell lung cancer (NSCLC) patients, who were treated with first-line chemotherapy" | Peptide Ion Signature for differentiation between Short PFS(Progression Free survival) versus long PFS | 19728888 |
| CancerPDF_ID344 | FKDLGEENFK | Serum albumin | Plasma | 613.803 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID345 | DLGEENFK | Serum albumin | Plasma | 476.221 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID346 | KLVAASQAALGL | Serum albumin | Plasma | 571.3475 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID347 | LVAASQAALGL | Serum albumin | Plasma | 507.3 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID348 | KVPQVSTPTLVEVSR | Serum albumin | Plasma | 547.3126667 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID4126 | AEDYLSVVLNQLC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4127 | AEDYLSVVLNQLCVL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4128 | AEDYLSVVLNQLCVLHEKTPV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4136 | AEVSKLVTDLTKV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4139 | AFAQYLQQCPF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4140 | AFAQYLQQCPFEDHV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4141 | AFAQYLQQCPFEDHVKL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4142 | AFAQYLQQCPFEDHVKLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4143 | AFAQYLQQCPFEDHVKLVNEV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4144 | AFAQYLQQCPFEDHVKLVNEVTEFAKTC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4280 | ALVLIAFAQYLQQCPFEDHVK | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4350 | AQYLQQCPFEDHV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4351 | AQYLQQCPFEDHVKLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4352 | AQYLQQCPFEDHVKLVNEVTEFAKTC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4382 | ATLRETYGEM | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4383 | ATLRETYGEMA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4384 | ATLRETYGEMADC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4385 | ATLRETYGEMADCC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4452 | CELFEQLGEYKFQNA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4453 | CELFEQLGEYKFQNAL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4533 | CVADESAENCDKSLHTLF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4544 | DAHKSEVAHRFKDLGEENFK | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4562 | DETYVPKEFNAETF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4563 | DETYVPKEFNAETFTF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4638 | DLPSLAADFV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4639 | DLPSLAADFVESKDV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4758 | ELFEQLGEYKF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4759 | ELFEQLGEYKFQN | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4760 | ELFEQLGEYKFQNA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4761 | ELFEQLGEYKFQNAL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4762 | ELFEQLGEYKFQNALL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4763 | ELFEQLGEYKFQNALLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4774 | EQLGEYKFQNA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4793 | FAQYLQQCPF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4798 | FDEFKPLVEEPQNLI | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4827 | FEQLGEYKF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4828 | FEQLGEYKFQNA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5120 | GEMADCCAKQEPERNECF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5352 | HCIAEVENDEMPADLPSLAADFV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5412 | IAFAQYLQQCPF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5482 | IKQNCELFEQLGEYKFQNAL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5602 | KKVPQVSTPTL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5611 | KLVNEVTEF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5612 | KLVNEVTEFAKTC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5618 | KQNCELFEQLGEYKFQNA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5619 | KQNCELFEQLGEYKFQNAL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5669 | KYICENQDSI | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5770 | LFGDKLCTV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5854 | LIAFAQYLQQCPF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5855 | LIAFAQYLQQCPFEDHV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5856 | LIAFAQYLQQCPFEDHVKLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5857 | LIAFAQYLQQCPFEDHVKLVNEV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5938 | LLVRYTKKVPQVSTPTL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5939 | LLVRYTKKVPQVSTPTLVEV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6024 | LQQCPFEDHVKLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6025 | LQQCPFEDHVKLVNEVTE | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6138 | LVRYTKKVPQVSTPTL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6139 | LVRYTKKVPQVSTPTLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6244 | NCELFEQLGEYKFQNAL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6245 | NCELFEQLGEYKFQNALL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6266 | NEVTEFAKTC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6267 | NEVTEFAKTCVA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6307 | NLIKQNCELFEQLGEYKFQNAL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6328 | NQLCVLHEKTPV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6560 | QNCELFEQLGEYKFQNA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6634 | QYLQQCPFEDHV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6635 | QYLQQCPFEDHVKLVNEV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6712 | RMPCAEDYLSV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6733 | RYTKKVPQVSTPTL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6734 | RYTKKVPQVSTPTLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6735 | RYTKKVPQVSTPTLVEV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6994 | SLQKFGERAFKAW | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6995 | SLQKFGERAFKAWAV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7450 | TKKVPQVSTPTL | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7451 | TKKVPQVSTPTLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7512 | TLRETYGEMADC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7513 | TLRETYGEMADCC | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7696 | VADESAENCDKSLHTLFGDKLCTV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7697 | VADESAENCDKSLHTLFGDKLCTVA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7906 | VLNQLCVLHEKTPV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7990 | VRPEVDVMCTA | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7994 | VRYTKKVPQVSTPTLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8279 | YGEMADCCAKQEPERNECF | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8387 | YTKKVPQVSTPT | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8388 | YTKKVPQVSTPTLV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8389 | YTKKVPQVSTPTLVE | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8390 | YTKKVPQVSTPTLVEV | Isoform 1 of Serum albumin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8606 | DAHKSEVAHRF | Serum albumin | Serum | 1295.64 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8607 | DAHKSEVAHRFKD | Serum albumin | Serum | 1538.76 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8649 | MKWVTFISLLFLFSSAYSRGVFRR | Albumin peptide (N terminal fragment of protein albumin) | Cerbrospinal fluid | NA | MALDI-TOF | Glioblastoma (Malignant brain tumor) | Downregulated in cancer as compare to normal control | 19674866 |
| CancerPDF_ID9533 | VAASQAALGL | Serum albumin | Serum | 450.75 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9534 | LVAASQAALGL | Serum albumin | Serum | 507.29 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9535 | KLVAASQAALG | Serum albumin | Serum | 514.81 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9536 | KLVAASQAALGL | Serum albumin | Serum | 571.33 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9537 | DAHKSEVAHR | Serum albumin | Serum | 575.27 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9538 | KKLVAASQAALG | Serum albumin | Serum | 578.83 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9539 | GKKLVAASQAALG | Serum albumin | Serum | 607.36 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9540 | KKLVAASQAALGL | Serum albumin | Serum | 635.38 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9541 | KVPQVSTPTLVEVSR | Serum albumin | Serum | 547.31 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9542 | FAEEGKKLVAASQAALGL | Serum albumin | Serum | 601.66 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9543 | DAHKSEVAHRFK | Serum albumin | Serum | 475.58 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9969 | FKAWAVARL | Serum albumin precursor | Urine | 1061.6096 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9973 | GEYKFQNAL | Serum albumin precursor | Urine | 1069.5603 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9988 | SQRFPKAEF | Serum albumin precursor | Urine | 1109.5951 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10015 | YARRHPDYS | Serum albumin precursor | Urine | 1164.5616 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10022 | GEYKFQNALL | Serum albumin precursor | Urine | 1182.6102 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10032 | VDETYVPKEF | Serum albumin precursor | Urine | 1226.5773 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10064 | TYVPKEFNAET | Serum albumin precursor | Urine | 1298.6345 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10073 | FKPLVEEPQNL | Serum albumin precursor | Urine | 1313.6999 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10095 | EVDETYVPKEF | Serum albumin precursor | Urine | 1355.5841 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10137 | YEYARRHPDYS | Serum albumin precursor | Urine | 1456.6268 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10139 | LQQCPFEDHVKL | Serum albumin precursor | Urine | 1456.7212 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10174 | LVRYTKKVPQVST | Serum albumin precursor | Urine | 1518.886 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10176 | LVKHKPKATKEQL | Serum albumin precursor | Urine | 1519.9039 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10184 | DAHKSEVAHRFKD | Serum albumin precursor | Urine | 1539.7496 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10193 | YEYARRHPDYSV | Serum albumin precursor | Urine | 1555.7054 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10229 | YLQQCPFEDHVKL | Serum albumin precursor | Urine | 1619.7803 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10243 | VDETYVPKEFNAET | Serum albumin precursor | Urine | 1641.6866 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10248 | DAHKSEVAHRFKDL | Serum albumin precursor | Urine | 1652.8514 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10250 | PFEDHVKLVNEVTE | Serum albumin precursor | Urine | 1655.8301 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10274 | DAHKSEVAHRFKDLG | Serum albumin precursor | Urine | 1709.8666 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10277 | VRYTKKVPQVSTPTL | Serum albumin precursor | Urine | 1717.0035 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated with 2.26 fold change in muscle invasive bladder cancer vs non invasive bladder cancer and non cancer samples | 21805675 |
| CancerPDF_ID10293 | VELVKHKPKATKEQL | Serum albumin precursor | Urine | 1748.0332 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10312 | EVDETYVPKEFNAET | Serum albumin precursor | Urine | 1770.7998 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10321 | LQQCPFEDHVKLVNE | Serum albumin precursor | Urine | 1798.8659 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10339 | LVRYTKKVPQVSTPTL | Serum albumin precursor | Urine | 1830.0049 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10344 | DAHKSEVAHRFKDLGE | Serum albumin precursor | Urine | 1838.9121 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10370 | HKSEVAHRFKDLGEEN | Serum albumin precursor | Urine | 1895.9285 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10389 | LLVRYTKKVPQVSTPTL | Serum albumin precursor | Urine | 1943.1669 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10392 | VRYTKKVPQVSTPTLVE | Serum albumin precursor | Urine | 1945.1115 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10398 | FAQYLQQCPFEDHVKL | Serum albumin precursor | Urine | 1965.9536 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10401 | AHKSEVAHRFKDLGEEN | Serum albumin precursor | Urine | 1966.9727 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10402 | DAHKSEVAHRFKDLGEE | Serum albumin precursor | Urine | 1967.9657 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10437 | HKSEVAHRFKDLGEENF | Serum albumin precursor | Urine | 2043.0109 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10442 | LVRYTKKVPQVSTPTLVE | Serum albumin precursor | Urine | 2058.1925 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10453 | DAHKSEVAHRFKDLGEEN | Serum albumin precursor | Urine | 2082.0004 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10465 | AHKSEVAHRFKDLGEENF | Serum albumin precursor | Urine | 2114.0375 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10471 | LQQCPFEDHVKLVNEVTE | Serum albumin precursor | Urine | 2128.0182 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10484 | IAFAQYLQQCPFEDHVKL | Serum albumin precursor | Urine | 2150.0682 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10495 | LLVRYTKKVPQVSTPTLVE | Serum albumin precursor | Urine | 2171.2803 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10499 | LVKHKPKATKEQLKAVMDD | Serum albumin precursor | Urine | 2179.3232 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10516 | DAHKSEVAHRFKDLGEENF | Serum albumin precursor | Urine | 2229.0114 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10518 | HKSEVAHRFKDLGEENFKA | Serum albumin precursor | Urine | 2242.1336 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10538 | FAQYLQQCPFEDHVKLVNE | Serum albumin precursor | Urine | 2308.0936 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10540 | AHKSEVAHRFKDLGEENFKA | Serum albumin precursor | Urine | 2313.1675 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10572 | ELVKHKPKATKEQLKAVMDD | Serum albumin precursor | Urine | 2407.3166 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10575 | DAHKSEVAHRFKDLGEENFKA | Serum albumin precursor | Urine | 2428.2029 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10588 | AQYLQQCPFEDHVKLVNEVTE | Serum albumin precursor | Urine | 2490.1956 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10589 | IAFAQYLQQCPFEDHVKLVNE | Serum albumin precursor | Urine | 2492.2137 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10595 | DAHKSEVAHRFKDLGEENFKAL | Serum albumin precursor | Urine | 2541.2328 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10600 | HKSEVAHRFKDLGEENFKALVL | Serum albumin precursor | Urine | 2567.3749 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10617 | FAQYLQQCPFEDHVKLVNEVTE | Serum albumin precursor | Urine | 2637.2685 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10618 | AHKSEVAHRFKDLGEENFKALVL | Serum albumin precursor | Urine | 2638.407 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10639 | DAHKSEVAHRFKDLGEENFKALVL | Serum albumin precursor | Urine | 2753.4445 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10650 | IAFAQYLQQCPFEDHVKLVNEVTE | Serum albumin precursor | Urine | 2821.3731 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10670 | DAHKSEVAHRFKDLGEENFKALVLIA | Serum albumin precursor | Urine | 2937.554 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10733 | IAFAQY | Serum albumin precursor | Urine | 712.3755 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10734 | PSLAADF | Serum albumin precursor | Urine | 720.3502 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10744 | IAFAQYL | Serum albumin precursor | Urine | 825.4551 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11342 | DAHKSEVAHRFKD | Serum albumin | Serum | 1538.759 | LC-MS | Melanoma | "Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11861 | KTYETTLEK | Serum albumin | Serum | 1111.5761 | LC-MS | Melanoma | "Present in 3 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11879 | KVPQVSTPTLVEVSR | Serum albumin | Serum | 1638.9305 | LC-MS | Melanoma | "Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12514 | TVATLRETY | Serum albumin | Serum | NA | LC-MS | Melanoma | "Present in 1 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12591 | VPQVSTPTLVEVSR | Serum albumin | Serum | 1510.8355 | LC-MS | Melanoma | "Present in 4 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12634 | YLYEIAR | Serum albumin | Serum | NA | LC-MS | Melanoma | "Present in 6 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12763 | DAHKSEVAHRFKDLGEENFKALVLIAFAQ | "Albumin, Isoform CRA_f" | Serum | 3281.7 | MALDI-TOF | Cervical cancer | Downregulated in Cervical squamous cell carcinoma vs healthy | 26282206 |
| CancerPDF_ID13274 | FQNALLVRY | Serum albumin | Plasma | 1123.626 | ?LC-MS | "Multiple myeloma patients, Acute myeloid leukemia" | NA | 20974924 |